In addition to genetic testing method, radiogenomics, which focusing on establishing the correlation between imaging features and molecular biomarkers, is expected to provide an alternative method to characterize and predict the MYCN amplification status of neuroblastoma noninvasively and inexpensively (8, 20). The gene discussed is MYCN; the disease is neuroblastoma.